Skip to main content

LifeSci Acquisition II Corp. (LSAQ)

NASDAQ: LSAQ · IEX Real-Time Price · USD
9.98 -0.01 (-0.10%)
Sep 20, 2021 11:57 AM EDT - Market open
Market Cap100.01M
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out10.01M
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Ex-Dividend Daten/a
Previous Close9.99
Day's Range9.97 - 9.98
52-Week Range9.76 - 12.68
Price Targetn/a
Est. Earnings Daten/a

About LSAQ

LifeSci Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2019 and is based in New York, New York.

IndustryShell Companies
IPO DateNov 20, 2020
Stock ExchangeNASDAQ
Ticker SymbolLSAQ
Full Company Profile


LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Busi...

NEW YORK, June 16, 2021 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company formed for the purpose of pursuing targets that are focused on healthcare innovation, today...

3 months ago - GlobeNewsWire

'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines

Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs.

4 months ago - Benzinga

Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B

Science 37, a life science company, is tapping the craze of a special purpose acquisition company to help it with a major public listing. Specifically, its is penning a merger agreement with LifeSci Acq...

4 months ago - Benzinga

Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operat...

LOS ANGELES & NEW YORK--(BUSINESS WIRE)-- #IPOs--Science 37, Inc. and LifeSci Acquisition II Corp announced that they have entered into a definitive business combination agreement.

4 months ago - Business Wire

LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering

NEW YORK, Nov. 20, 2020 (GLOBE NEWSWIRE) -- LifeSci Acquisition II Corp. (NASDAQ: LSAQ), a blank check company targeting the biopharma sector, announced today that it priced its initial public offering ...

10 months ago - GlobeNewsWire